CASP3 and neoplasm: To evaluate Rimonabant-mediated cell death induction in CSCs, caspase-3 activity was measured with FACS-based CaspGlow active staining kit, gating on about 10% of TOP-GFPhigh (CSCs) and, in same experiment, on about 10% TOP-GFPlow (differentiated tumor cells).